搜尋
Tvardi Therapeutics Ord Shs
TVRD添加自選
1.320USD
-0.250-15.92%
收盤 09-23 16:00（美東）
16.49M總市值
0.20本益比TTM
關於 公司
Tvardi Therapeutics Ord Shs 簡介
公司代碼- -
公司名稱- -
上市日期- -
CEO- -
員工數量- -
證券類型- -
年結日- -
公司地址- -
城市- -
上市交易所- -
國家- -
郵編- -
電話- -
網址- -
公司代碼- -
上市日期- -
CEO- -
Tvardi Therapeutics Ord Shs公司高管
名稱
名稱/職務
職務
持股
持股變動
Dr. Susan Shiff, Ph.D.
Dr. Susan Shiff, Ph.D.
Independent Director
Independent Director
5.61K
--
Dr. Susan Shiff, Ph.D.
Dr. Susan Shiff, Ph.D.
Independent Director
Independent Director
5.61K
--
Mr. Sujal A. Shah
Mr. Sujal A. Shah
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Wallace L. Hall, Jr.
Mr. Wallace L. Hall, Jr.
Independent Director
Independent Director
--
--
Mr. Michael S. Wyzga
Mr. Michael S. Wyzga
Independent Director
Independent Director
--
--
Dr. Imran Alibhai, Ph.D.
Dr. Imran Alibhai, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Ms. Cynthia Smith
Ms. Cynthia Smith
Independent Director
Independent Director
--
--
Mr. Dan Conn, J.D.
Mr. Dan Conn, J.D.
Chief Financial Officer, Corporate Secretary
Chief Financial Officer, Corporate Secretary
--
--
Dr. John Kauh, M.D.
Dr. John Kauh, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Sujal A. Shah
Mr. Sujal A. Shah
Independent Chairman of the Board
Independent Chairman of the Board
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Dr. Susan Shiff, Ph.D.
Dr. Susan Shiff, Ph.D.
Independent Director
Independent Director
5.61K
--
Dr. Susan Shiff, Ph.D.
Dr. Susan Shiff, Ph.D.
Independent Director
Independent Director
5.61K
--
Mr. Sujal A. Shah
Mr. Sujal A. Shah
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Wallace L. Hall, Jr.
Mr. Wallace L. Hall, Jr.
Independent Director
Independent Director
--
--
Mr. Michael S. Wyzga
Mr. Michael S. Wyzga
Independent Director
Independent Director
--
--
Dr. Imran Alibhai, Ph.D.
Dr. Imran Alibhai, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
常見問題
Tvardi Therapeutics Ord Shs的前五大股東是誰？
Tvardi Therapeutics Ord Shs的前五大股東如下：Dr. Susan Shiff, Ph.D.
哪個業務部門對Tvardi Therapeutics Ord Shs的收入貢獻最大？
在2026Q4，Other revenue 業務部門對Tvardi Therapeutics Ord Shs的收入貢獻最大，創收1.32M，占總收入的51.50% 。